Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
RPRX
Royalty Pharma plc
NASDAQ · Pharmaceutical Preparations
Last close
$58.36
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
RECENT INSIDER TRADES
2026-10-05
· Urist Marshall
(EVP, Research & Investments)
· SELL
2026-09-30
· Bassler Bonnie L
(Director)
· OTHER
2026-09-30
· Urist Marshall
(EVP, Research & Investments)
· SELL
2026-09-24
· Hite Christopher
(EVP & Chairman, Partnering)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
685
Shares held
404,766,529
Value
$20.80B
Percent of shares outstanding
104.29%
As of quarter end
2026-06-30
RECENT NEWS
Royalty Pharma EVP Marshall Urist sells $235,594 in shares
Royalty Pharma to report Q3 2026 results on November 4
Royalty Pharma EVP Christopher Hite sells $5.85m in shares
Royalty Pharma presents at Bank of America Global Healthcare Conference
Royalty Pharma gives $7.5 million to Blood Cancer United for Therapy Acceleration Program
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Royalty Pharma plc (RPRX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit